These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015. Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510 [TBL] [Abstract][Full Text] [Related]
8. Molecular typing of Burkholderia cepacia complex isolated from patients attending an Italian Cystic Fibrosis Centre. Teri A; Sottotetti S; Biffi A; Girelli D; D'Accico M; Arghittu M; Colombo C; Corti F; Pizzamiglio G; Cariani L New Microbiol; 2018 Apr; 41(2):141-144. PubMed ID: 29498745 [TBL] [Abstract][Full Text] [Related]
9. Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center. Cunha MV; Pinto-de-Oliveira A; Meirinhos-Soares L; Salgado MJ; Melo-Cristino J; Correia S; Barreto C; Sá-Correia I J Clin Microbiol; 2007 May; 45(5):1628-33. PubMed ID: 17360834 [TBL] [Abstract][Full Text] [Related]
10. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection. Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078 [TBL] [Abstract][Full Text] [Related]
11. [Bacteria of the Burkholderia cepacia complex: epidemiology and diagnosis of infection in patients with cystic fibrosis]. Dřevínek P Epidemiol Mikrobiol Imunol; 2014 Feb; 63(1):18-26. PubMed ID: 24730990 [TBL] [Abstract][Full Text] [Related]
12. Burkholderia cepacia complex infection in patients with cystic fibrosis. Mahenthiralingam E; Baldwin A; Vandamme P J Med Microbiol; 2002 Jul; 51(7):533-538. PubMed ID: 12132768 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center. Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935 [TBL] [Abstract][Full Text] [Related]
14. Identification of Burkholderia cepacia complex pathogens by rapid-cycle PCR with fluorescent hybridization probes. Vonberg RP; Häußler S; Vandamme P; Steinmetz I J Med Microbiol; 2006 Jun; 55(Pt 6):721-727. PubMed ID: 16687590 [TBL] [Abstract][Full Text] [Related]
15. The clinical course of Burkholderia cepacia complex bacteria respiratory infection in cystic fibrosis patients. Correia S; Nascimento C; Pereira L; Cunha MV; Sá-Correia I; Barreto C Rev Port Pneumol; 2008; 14(1):5-26. PubMed ID: 18265915 [TBL] [Abstract][Full Text] [Related]
17. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance. Coutinho CP; Barreto C; Pereira L; Lito L; Melo Cristino J; Sá-Correia I J Med Microbiol; 2015 Aug; 64(8):927-935. PubMed ID: 26002942 [TBL] [Abstract][Full Text] [Related]
19. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. Reik R; Spilker T; Lipuma JJ J Clin Microbiol; 2005 Jun; 43(6):2926-8. PubMed ID: 15956421 [TBL] [Abstract][Full Text] [Related]
20. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand. Kidd TJ; Douglas JM; Bergh HA; Coulter C; Bell SC Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]